PEG-somatropin
GenSci 031 CT
Phase 2 mab active
Quick answer
PEG-somatropin for Short Stature Children Born Small for Gestational Age (SGA) is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Short Stature Children Born Small for Gestational Age (SGA)
- Phase
- Phase 2
- Modality
- mab
- Status
- active